Also, in locally advanced PCa tumors, NWD1 immunostaining was higher in primary tumors that failed to achieve pathological complete response (pCR) to anti-androgen treatment in the neoadjuvant setting [55, 56]. This evidence concerns the gene NWD1 and posterior cortical atrophy.